Re: Biogen/Eisai Scrap Aducanumab
in response to
by
posted on
Mar 24, 2019 09:54AM
We may not know how many of the 467 patients with mild cognitive impairment enrolled in the BOM that underwent MoCA actually suffer from vascular dementia. Or does it really matter if the MoCA scores are much improved from baseline to final adjudication of the BOM trial in this regard?
Koo